Anaphylaxis epidemiology and demographics

Jump to navigation Jump to search

Anaphylaxis Microchapters


Patient Information


Historical Perspective




Differentiating Anaphylaxis from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis


History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

Other Diagnostic Studies


Medical Therapy


Primary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Anaphylaxis epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides


American Roentgen Ray Society Images of Anaphylaxis epidemiology and demographics

All Images
Echo & Ultrasound
CT Images

Ongoing Trials at Clinical

US National Guidelines Clearinghouse

NICE Guidance

FDA on Anaphylaxis epidemiology and demographics

CDC on Anaphylaxis epidemiology and demographics

Anaphylaxis epidemiology and demographics in the news

Blogs on Anaphylaxis epidemiology and demographics

Directions to Hospitals Treating Anaphylaxis

Risk calculators and risk factors for Anaphylaxis epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1], Associate Editor(s)-in-Chief: Dushka Riaz, MD

Epidemiology and Demographics


  • In 2006, the lifetime prevalence of Anaphylaxis was estimated to be 0.05% to 2% in the United States. However it is believed that this is an underestimation because the disease is underdiagnosed. [1]

Case-fatality rate/Mortality rate


  • Patients of all age groups may develop anaphylaxis, however, children and adolescents account for the majority of cases.[3]



  • Anaphylaxis affects men and women equally with more women being admitted to the hospital for the disease. [1]


Developed Countries

An estimated 1.24% to 16.8% of the United States population is considered at risk for developing anaphylaxis if they are exposed to one or more allergens. Anaphylaxis results in fewer than 1,000 deaths per year in the U.S and the most common presentation is cardiovascular collapse [4] [5]


  1. 1.0 1.1 LoVerde D, Iweala OI, Eginli A, Krishnaswamy G (2018). "Anaphylaxis". Chest. 153 (2): 528–543. doi:10.1016/j.chest.2017.07.033. PMC 6026262. PMID 28800865.
  2. Ma L, Danoff TM, Borish L (2014). "Case fatality and population mortality associated with anaphylaxis in the United States". J Allergy Clin Immunol. 133 (4): 1075–83. doi:10.1016/j.jaci.2013.10.029. PMC 3972293. PMID 24332862.
  3. Lieberman P, Camargo CA, Bohlke K, Jick H, Miller RL, Sheikh A; et al. (2006). "Epidemiology of anaphylaxis: findings of the American College of Allergy, Asthma and Immunology Epidemiology of Anaphylaxis Working Group". Ann Allergy Asthma Immunol. 97 (5): 596–602. doi:10.1016/S1081-1206(10)61086-1. PMID 17165265.
  4. Neugut, Alfred, Anita Ghatak and Rachel Miller. "Anaphylaxis in the United States: An Investigation Into Its Epidemiology." Arch Intern Med. 161.108 January 2001 15-21. 29 January 2007 <>.
  5. "FASTSTATS - Deaths and Mortality". Retrieved 2013-02-13.

Template:WikiDoc Sources CME Category::Cardiology